Space Foundation Names Aspen Laser Systems, LLC as Space Certification Program Partner

February 8, 2021

Space Foundation, a nonprofit advocate organization founded in 1983, today announced Aspen Laser Systems, LLC as the most recent company to become a Space Certification partner.

Aspen Laser Systems has adapted a technology originally developed for NASA into a method of delivering noninvasive and painless light-based photobiomodulation (PBMT) therapy treatment for conditions such as arthritis, tendonitis, and acute joint or muscle injuries.

Space Certification Program awards a “seal of approval” to commercial companies that demonstrate products and services in technology, data, education and creative markets that originate from space technology and are a source of inspiration for discoveries and innovations in the global space ecosystem. Today, every community, infrastructure, and aspect of modern life is either profoundly dependent on or indirectly affected by space-related innovations.

Aspen Laser President Charles Vorwaller commented on the partnership saying, “Aspen Laser is extremely proud of our new relationship with Space Foundation. Our company and products will benefit greatly from this unique recognition, and we firmly believe that our consistent use of the Space Certification Program and official seals will expand the awareness of photobiomodulation. The Aspen Laser products are a great addition for any healthcare professional, whether experienced or just starting out with photobiomodulation.”

Carah Barbarick, space awareness programs manager at Space Foundation, also shared, “Aspen Laser Systems is an exciting addition to our Space Certification partners. With a focus on raising the standards in medical care, they are using space technology to improve the lives of all their patients, both human and animal.”

Therapeutic Technology Developed for NASA Evolved for Clinical Use

The National Aeronautics and Space Administration (NASA) became involved in research utilizing light therapy beginning in the 1990s, with many of these findings being a springboard for additional scientific and clinical studies. In 1993, Quantum Devices, Inc. developed an LED for NASA to use in their plant growth experiments. These experiments demonstrated that red LED wavelengths could boost plant growth. Coincidentally, the scientists noticed that their own skin lesions began to heal faster as well. NASA subsequently began to study the use of LED and infrared wavelengths to increase the metabolism of human cells and for medical uses to improve healing for astronauts in space.

Many medications (RX and OTC) and therapy products treat symptoms that only provide temporary relief or short-term benefits. In contrast, PBMT is a preferable treatment because it provides energy through specific wavelengths of light that penetrate inside the body and into damaged and unhealthy cells, triggering a chemical response within the cells that result in stimulating the body to heal itself.

Aspen Laser Systems, LLC was founded by Vorwaller in 2014 with the mission to provide technology for medical doctors and therapists to use in helping their patients with better pain management and a faster recovery. Aspen Laser is an FDA-registered medical device company specializing in photomedicine with a unique focus and expertise in photobiomodulation which is an alternative to pharmaceuticals and other therapeutic modalities.

According to Vorwaller, “We became aware of the research that NASA was doing in the early 1990s initially using LED low level light therapy. Today, the Aspen Laser products are the result of an evolution from this early technology. Over time, we increased the power level of the diodes, added additional infrared wavelengths, and concentrated the light output, resulting in targeted laser therapy that provides a higher concentration of light energy into an area of the body that requires it, due to localized pain or injury.”

Aspen Laser Systems’ national headquarters is based in Lindon, Utah, with an additional location in Ft. Pierce, Florida.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version